This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Areas
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer cross
BAYER FOR PROFESSIONALSYour Resource Portal
  • Ophthalmology
  • EYLEA® (aflibercept) 8 mg
  • EYLEA® (aflibercept) 2 mg
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Kerendia®▼ (finerenone)
  • Xarelto® (rivaroxaban)
  • Women's Health
  • Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone)
  • Jaydess®▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
  • Ophthalmology
  • Oncology
  • Cardiology
  • Women's Health
  • Ophthalmology Resources
  • Oncology Resources
  • Cardiology Resources
  • Women's Health Resources
  • Ophthalmology Events & On Demand Webinars
  • Oncology Events & On Demand Webinars
  • Cardiology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Ophthalmology Learning Zone
  • Oncology Learning Zone
  • Cardiology Learning Zone
  • Women's Health Learning Zone
  • Ophthalmology Podcasts
  • Oncology Podcasts
  • Cardiology Podcasts
  • Women's Health Podcasts
closesearch
Recent Searches
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    Resource Banner Image

    Patient Support Materials

    Ophthalmology Patient Support Materials
    Access our range of downloadable patient support booklets and other resources
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-3117, March 2026
    Xarelto® (rivaroxaban) Patient Support Materials
    Access useful, downloadable cardiovascular resources for patients
    Xarelto Prescribing Information
    PP-XAR-GB-3663, October 2024
    Kerendia®▼(finerenone) Patient Support Materials
    Access useful, downloadable resources for patients
    Kerendia Prescribing Information
    RP-KER-GB-1189, October 2025
    Patient Materials
    Useful, downloadable resources
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0111, December 2025

    Case Studies

    View more
    mCRPC Patient Case Study
    A Nuclear Medicine perspective - Xofigo®▼ (radium-223 dichloride)
    Xofigo Prescribing Information
    PP-XOF-GB-0575, June 2024
    mCRPC Patient Case Study
    An Oncologist Perspective - Xofigo®▼ (radium-223 dichloride)
    Xofigo Prescribing Information
    PP-XOF-GB-0574, June 2024
    nmCRPC Patient Case Study
    NUBEQA® (darolutamide) - An Oncologist Perspective
    NUBEQA Prescribing Information
    PP-NUB-GB-2031, January 2025
    nmCRPC Patient Case Study
    NUBEQA® (darolutamide) - A Urologist Perspective
    NUBEQA Prescribing Information
    PP-NUB-GB-2038, January 2025

    Women's Health Resources

    View more
    Counselling patients
    Simple steps from INTRA to successfully counsel women about intrauterine contraception (IUC) in under 7 minutes.
    PP-PF-WHC-IUS-GB-0062, February 2024
    Patient Materials
    Useful, downloadable resources
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0111, December 2025
    Fitter resources
    Step-by-step instructions to guide you through the preparation and fitting of IUS/IUD.
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0060, February 2024
    Fitting Service Resources
    Access useful, downloadable IUS and LARC resources for HCPs and patients.
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0109, August 2025

    Cardiology Resources

    View more
    Navigating ATTR-CM Diagnosis
    Beyonttra®▼ (acoramidis) | Explore resources on Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Beyonttra Prescribing Information
    PP-PF-CAR-GB-0060, October 2025

    Oncology Resources

    View more
    Gathering consensus on mHSPC Treatment
    NUBEQA® (darolutamide)
    NUBEQA Prescribing Information
    PP-NUB-GB-2230, March 2025
    mCRPC Patient Case Study
    A Nuclear Medicine perspective - Xofigo®▼ (radium-223 dichloride)
    Xofigo Prescribing Information
    PP-XOF-GB-0575, June 2024
    mCRPC Patient Case Study
    An Oncologist Perspective - Xofigo®▼ (radium-223 dichloride)
    Xofigo Prescribing Information
    PP-XOF-GB-0574, June 2024
    Xofigo®▼ (radium-223 dichloride) Resources
    Xofigo Prescribing Information
    PP-XOF-GB-0626, April 2025

    Ophthalmology Resources

    View more
    Real World Experience
    Practical insights into the experiences of clinicians implementing treatment with EYLEA® (aflibercept) 8 mg in the UK
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-3082, March 2026
    Ophthalmology Resources
    Access useful, downloadable ophthalmology resources
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-3081, March 2026
    Ophthalmology Patient Support Materials
    Access our range of downloadable patient support booklets and other resources
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-3117, March 2026
    EYLEA® (aflibercept) Risk Minimisation Materials
    Visit to access Risk Minimisation Materials for EYLEA® (aflibercept)
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2647, December 2024